title: Immunization against experimental murine salmonellosis with liposome-associated O-antigen.
abstract: Partially delipidated Salmonella typhimurium (O-1,4,5,12) lipopolysaccharide was incorporated into small multilamellar liposomes composed of either naturally occurring or synthetic phospholipids. Vaccination of mice with the liposome-lipopolysaccharide complexes induced a cellular response specific for O-1,4,5,12 determinants, as determined by the development of a delayed-type hypersensitivity reaction. The liposome-lipopolysaccharide vaccines were significantly more effective, compared with other nonviable vaccines tested, in protecting mice against a lethal intravenous challenge infection with virulent S. typhimurium. Protection afforded by the liposome-lipopolysaccharide vaccines was comparable to that conferred by a live S. typhimurium vaccine. Results suggest that liposome-induced modulation of the host immune response in favor of cell-mediated immunity may be more efficacious in preventing diseases in which cell-mediated immunity is of prime importance.
authors.forename: J V
authors.initials: JV
authors.lastname: Desiderio
authors.forename: S G
authors.initials: SG
authors.lastname: Campbell
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D000942:Antigens, Bacterial / Q000008:administration & dosage*; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular; D007114:Immunization; D008070:Lipopolysaccharides / Q000008:administration & dosage; D008081:Liposomes / Q000008:administration & dosage*; D051379:Mice; D019081:O Antigens; D012480:Salmonella Infections / Q000276:immunology / Q000517:prevention & control*
chemical_list: D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D008070:Lipopolysaccharides; D008081:Liposomes; D019081:O Antigens